PPT-Switching from daily basal insulin to weekly

LAPS Insulin 115 LAPS CA Exendin4 combination showed improved efficacy and body weight gain reduction A Time course changes in HbA1c LAPS Combo LAPS Insulin 115 LAPS CAExendin4. LAPS. Insulin. 115 + . LAPS. CA. -Exendin-4 combination showed improved efficacy and body weight gain reduction. . (A) Time course changes in HbA1c. LAPS. Combo. (. LAPS. Insulin. 115 + . LAPS. CA-Exendin-4). the Treatment of T1DM and T2DM. Lawrence Blonde, MD, FACP, FACE. Director of the . Ochsner. Diabetes Clinical Research Unit. Ochsner. Medical Center. New Orleans, Louisiana. Vivian . A. Fonseca, MD, FRCP. The Basal Bolus order set is intended for the management of hospitalized patients with poorly controlled blood glucose (greater than 140 mg/. dL. random blood sugar). The Basal Bolus Insulin Order Set. Program Goals. The . Incretin System: Response to Oral Glucose. Injected Incretin-based Agents: GLP-1 Receptor Agonists. Oral Incretin-based Agents: DPP-4 Inhibitors . Main Pathophysiological Defects in T2D. August 18, 2017. Disclaimer. This activity features cases that are loosely based on two famous musicians who had diabetes: Jerry Garcia and Ella Fitzgerald. Publicly available medical information was used to construct the core elements of the cases. When information was not available, the activity content planners added relevant, but fictional, details to devise an meaningful educational experience.  . Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator Basal Bolus versus Premixed . ADA Diabetes Management Algorithm 2015 . Need for Early and aggressive treatment. Legacy effect: early vs late glycemic control and complications risk. Aggressive glycemic control:. Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . A Amouzegar, MD. Endocrine Research Center, Research Institute For Endocrine Sciences, Shahid Beheshti University, Tehran . Agenda. Rationale for Early Insulin Therapy. Which insulin is appropriate for being initiated?. Intensive Insulin Management 10Basal: Once-daily, either morning or bedtime(alternative: NPH morning and bedtime)Bolus: Fast-acting insulin before each meal;(alternative: R may be used)Premeal insulin Markus Menzen. 1. ; Niels Væver Hartvig. 2. ; Anne Kaas. 2. ; Nikoline Nygård Knudsen. 2. ; Johan Jendle. 3. 1. Division of Internal Medicine, Department of Gastroenterology and Diabetology, Community Hospital Bonn, Bonn, Germany. FOCUS OF PROFILE GLULISINE. The main target. To normalize . Blood glucose. Delay . progression. Reduce . complication. s. Diabetes Management. ᵛ. ᵛ. fasting. postprandial. 1.Fasting hyperglycemia . Glucose homeostasis in blood. Gluconeogenesis in liver (making glucose from non-carbohydrate sources, e.g., lactate). Oral antidiabetic medication. Insulin . sensitisers. Biguanides. Thiazolidinediones. Research Institute For Endocrine Sciences. Endocrine Research Center. Shahid Beheshti University. 04.04.1397. Outlines. Case presentation. Barriers of insulin therapy. Action-profile. Types of basal .